Literature DB >> 17158178

Glucose sensing by hypothalamic neurones and pancreatic islet cells: AMPle evidence for common mechanisms?

Philip D Mountjoy1, Guy A Rutter.   

Abstract

A fuller understanding of the central mechanisms involved in controlling food intake and metabolism is likely to be crucial for developing treatments to combat the growing problem of obesity in Westernised societies. Within the hypothalamus, specialized neurones respond to both appetite-regulating hormones and circulating metabolites to regulate feeding behaviour accordingly. Thus, the activity of hypothalamic glucose-excited and glucose-inhibited neurones is increased or decreased, respectively, by an increase in local glucose concentration. These 'glucose-sensing' neurones may therefore play a key role in the central regulation of food intake and potentially in the regulation of blood glucose concentrations. Whilst the intracellular signalling mechanisms through which glucose-sensing neurones detect changes in the concentration of the sugar have been investigated quite extensively, many elements remain poorly understood. Furthermore, the similarities, or otherwise, with other nutrient-sensing cells, including pancreatic islet cells, are not completely resolved. In this review, we discuss recent advances in this field and explore the potential involvement of AMP-activated protein kinase and other nutrient-regulated protein kinases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17158178     DOI: 10.1113/expphysiol.2006.036004

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  24 in total

1.  Synapses of amphids defective (SAD-A) kinase promotes glucose-stimulated insulin secretion through activation of p21-activated kinase (PAK1) in pancreatic β-Cells.

Authors:  Jia Nie; Chao Sun; Omar Faruque; Guangming Ye; Jia Li; Qiangrong Liang; Zhijie Chang; Wannian Yang; Xiao Han; Yuguang Shi
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

Review 2.  The regulation of food intake in mammalian hibernators: a review.

Authors:  Gregory L Florant; Jessica E Healy
Journal:  J Comp Physiol B       Date:  2011-11-12       Impact factor: 2.200

3.  Effects of atypical antipsychotics and haloperidol on PC12 cells: only aripiprazole phosphorylates AMP-activated protein kinase.

Authors:  Goro Takami; Miyuki Ota; Akira Nakashima; Yoko S Kaneko; Keiji Mori; Toshiharu Nagatsu; Akira Ota
Journal:  J Neural Transm (Vienna)       Date:  2010-08-05       Impact factor: 3.575

4.  "AMPing up" our understanding of the hypothalamic control of energy balance.

Authors:  Kevin W Williams; Roberto Coppari; Joel K Elmquist
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

5.  Glucagon-like peptide 1 (GLP-1) can reverse AMP-activated protein kinase (AMPK) and S6 kinase (P70S6K) activities induced by fluctuations in glucose levels in hypothalamic areas involved in feeding behaviour.

Authors:  Verónica Hurtado-Carneiro; Carmen Sanz; Isabel Roncero; Patricia Vazquez; Enrique Blazquez; Elvira Alvarez
Journal:  Mol Neurobiol       Date:  2012-02-05       Impact factor: 5.590

Review 6.  Multiple hypothalamic circuits sense and regulate glucose levels.

Authors:  Mahesh Karnani; Denis Burdakov
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-11-03       Impact factor: 3.619

Review 7.  Nutrient excess and altered mitochondrial proteome and function contribute to neurodegeneration in diabetes.

Authors:  Subir K Roy Chowdhury; Rick T Dobrowsky; Paul Fernyhough
Journal:  Mitochondrion       Date:  2011-07-02       Impact factor: 4.160

Review 8.  Role of AMP-activated protein kinase in the control of appetite.

Authors:  B Kola
Journal:  J Neuroendocrinol       Date:  2008-04-28       Impact factor: 3.627

9.  The rate-limiting step for glucose transport into the hypothalamus is across the blood-hypothalamus interface.

Authors:  Carol Poitry-Yamate; HongXia Lei; Rolf Gruetter
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

10.  Evidence for neuroendocrine function of a unique splicing form of TCF7L2 in human brain, islets and gut.

Authors:  L Prokunina-Olsson; J L Hall
Journal:  Diabetologia       Date:  2009-12-24       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.